$REGN
REGENERON PHARMACEUTICALS, INC.

2019 Q2 Form 10-Q Financial Statement

#000153217619000026 Filed on August 06, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2
Revenue $1.578B $1.608B
YoY Change -1.88% 9.38%
Cost Of Revenue $145.8M $91.70M
YoY Change 59.0% 117.64%
Gross Profit $1.432B $1.516B
YoY Change -5.57% 6.19%
Gross Profit Margin 90.76% 94.3%
Selling, General & Admin $294.6M $364.8M
YoY Change -19.24% 18.86%
% of Gross Profit 20.57% 24.06%
Research & Development $885.5M $529.3M
YoY Change 67.3% 3.79%
% of Gross Profit 61.84% 34.91%
Depreciation & Amortization $52.10M $33.60M
YoY Change 55.06% -4.27%
% of Gross Profit 3.64% 2.22%
Operating Expenses $1.180B $894.1M
YoY Change 31.99% 9.45%
Operating Profit $315.6M $622.2M
YoY Change -49.28% 13.06%
Interest Expense $8.000M $6.900M
YoY Change 15.94% 27.75%
% of Operating Profit 2.53% 1.11%
Other Income/Expense, Net -$90.90M $33.90M
YoY Change -368.14% -238.58%
Pretax Income $224.7M $656.1M
YoY Change -65.75% 24.77%
Income Tax $31.60M $104.7M
% Of Pretax Income 14.06% 15.96%
Net Earnings $193.1M $551.4M
YoY Change -64.98% 42.22%
Net Earnings / Revenue 12.24% 34.29%
Basic Earnings Per Share $1.77 $5.12
Diluted Earnings Per Share $1.68 $4.82
COMMON SHARES
Basic Shares Outstanding 109.2M shares 107.8M shares
Diluted Shares Outstanding 114.6M shares 114.5M shares

Balance Sheet

Concept 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.670B $1.684B
YoY Change 58.55% 32.81%
Cash & Equivalents $1.046B $917.9M
Short-Term Investments $1.624B $766.0M
Other Short-Term Assets $598.0M $460.0M
YoY Change 30.0% 20.73%
Inventory $1.317B $928.6M
Prepaid Expenses
Receivables $1.920B $1.534B
Other Receivables $0.00 $0.00
Total Short-Term Assets $6.651B $4.815B
YoY Change 38.13% 24.74%
LONG-TERM ASSETS
Property, Plant & Equipment $2.677B $2.462B
YoY Change 8.73% 8.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.885B $2.045B
YoY Change 41.08% 92.02%
Other Assets $139.8M $85.67M
YoY Change 63.19% 131.77%
Total Long-Term Assets $6.523B $5.137B
YoY Change 26.97% 20.98%
TOTAL ASSETS
Total Short-Term Assets $6.651B $4.815B
Total Long-Term Assets $6.523B $5.137B
Total Assets $13.17B $9.952B
YoY Change 32.37% 22.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $244.0M $172.0M
YoY Change 41.86% 13.91%
Accrued Expenses $877.0M $671.0M
YoY Change 30.7% 23.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.713B $1.331B
YoY Change 28.69% 29.37%
LONG-TERM LIABILITIES
Long-Term Debt $711.0M $706.0M
YoY Change 0.71% 0.71%
Other Long-Term Liabilities $267.9M $190.0M
YoY Change 40.99% 63.92%
Total Long-Term Liabilities $267.9M $190.0M
YoY Change 40.99% 63.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.713B $1.331B
Total Long-Term Liabilities $267.9M $190.0M
Total Liabilities $3.418B $2.766B
YoY Change 23.58% 6.96%
SHAREHOLDERS EQUITY
Retained Earnings $5.918B $3.839B
YoY Change 54.15% 60.98%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $441.8M $353.9M
YoY Change 24.85% 11.89%
Treasury Stock Shares 4.018M shares 3.885M shares
Shareholders Equity $9.756B $7.186B
YoY Change
Total Liabilities & Shareholders Equity $13.17B $9.952B
YoY Change 32.37% 22.77%

Cashflow Statement

Concept 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income $193.1M $551.4M
YoY Change -64.98% 42.22%
Depreciation, Depletion And Amortization $52.10M $33.60M
YoY Change 55.06% -4.27%
Cash From Operating Activities $188.3M $394.6M
YoY Change -52.28% -1389.54%
INVESTING ACTIVITIES
Capital Expenditures -$94.60M -$112.0M
YoY Change -15.54% 104.38%
Acquisitions
YoY Change
Other Investing Activities -$741.4M -$373.0M
YoY Change 98.77% 222.94%
Cash From Investing Activities -$836.0M -$485.0M
YoY Change 72.37% 184.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.30M -11.20M
YoY Change 36.61% -108.39%
NET CHANGE
Cash From Operating Activities 188.3M 394.6M
Cash From Investing Activities -836.0M -485.0M
Cash From Financing Activities -15.30M -11.20M
Net Change In Cash -663.0M -101.6M
YoY Change 552.56% 50.3%
FREE CASH FLOW
Cash From Operating Activities $188.3M $394.6M
Capital Expenditures -$94.60M -$112.0M
Free Cash Flow $282.9M $506.6M
YoY Change -44.16% 1993.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Central Index Key
EntityCentralIndexKey
0000872589
CY2019Q2 regn Finance Lease Rightof Use Asset Accumulated Amortization
FinanceLeaseRightofUseAssetAccumulatedAmortization
68900000 USD
CY2018Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
45500000 USD
CY2017Q1 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P5Y
CY2017Q1 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P5Y
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
3990021 shares
CY2019Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
4018269 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-19034
dei Entity Registrant Name
EntityRegistrantName
REGENERON PHARMACEUTICALS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3444607
dei Entity Address Address Line1
EntityAddressAddressLine1
777 Old Saw Mill River Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Tarrytown,
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10591-6707
dei City Area Code
CityAreaCode
914
dei Local Phone Number
LocalPhoneNumber
847-7000
dei Security12b Title
Security12bTitle
Common Stock - par value $.001 per share
dei Trading Symbol
TradingSymbol
REGN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1045500000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1467700000 USD
CY2019Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1624200000 USD
CY2018Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1342200000 USD
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1920200000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1723700000 USD
CY2019Q2 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
252000000.0 USD
CY2018Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
226400000 USD
CY2019Q2 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
283700000 USD
CY2018Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
293100000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
1317200000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
1151200000 USD
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
208200000 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
243300000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
6651000000.0 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
6447600000 USD
CY2019Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
2884600000 USD
CY2018Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1755000000.0 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2676600000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2575800000 USD
CY2019Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
821600000 USD
CY2018Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
828700000 USD
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
139800000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
127400000 USD
CY2019Q2 us-gaap Assets
Assets
13173600000 USD
CY2018Q4 us-gaap Assets
Assets
11734500000 USD
CY2019Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
244000000.0 USD
CY2018Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
218200000 USD
CY2019Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
876700000 USD
CY2018Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
772100000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1713100000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1442800000 USD
CY2019Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
711300000 USD
CY2018Q4 regn Capitalandfacilityleaseobligationsnoncurrent
Capitalandfacilityleaseobligationsnoncurrent
708500000 USD
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
267900000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
361700000 USD
CY2019Q2 us-gaap Liabilities
Liabilities
3417700000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
2977200000 USD
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4263600000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3911600000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5918200000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5254300000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15800000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12300000 USD
CY2019Q2 us-gaap Treasury Stock Value
TreasuryStockValue
441800000 USD
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
396400000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
9755900000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
8757300000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13173600000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11734500000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1933700000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1608000000.0 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3645500000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3119500000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1048300000 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
529300000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1690100000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1027900000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
417300000 USD
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
364800000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
828100000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
695600000 USD
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
1618100000 USD
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
985800000 USD
us-gaap Costs And Expenses
CostsAndExpenses
2849900000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1930100000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
315600000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
622200000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
795600000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1189400000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-82900000 USD
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
40800000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9100000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
65400000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
8000000.0 USD
CY2018Q2 us-gaap Interest Expense
InterestExpense
6900000 USD
us-gaap Interest Expense
InterestExpense
15700000 USD
us-gaap Interest Expense
InterestExpense
13300000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-90900000 USD
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
33900000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-24800000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
52100000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
224700000 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
656100000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
770800000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1241500000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31600000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
104700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
116600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
212100000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
193100000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
551400000 USD
us-gaap Net Income Loss
NetIncomeLoss
654200000 USD
us-gaap Net Income Loss
NetIncomeLoss
1029400000 USD
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.77
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.56
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.68
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.82
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.97
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109200000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109100000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107700000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114600000 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115000000.0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114700000 shares
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
193100000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
551400000 USD
us-gaap Net Income Loss
NetIncomeLoss
654200000 USD
us-gaap Net Income Loss
NetIncomeLoss
1029400000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
14400000 USD
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3400000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
30500000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-7700000 USD
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
600000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1400000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-2400000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
2000000.0 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
206100000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
555400000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
682300000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1023700000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
8757300000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
140900000 USD
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10700000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
10500000 USD
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
54000000.0 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
114800000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
461100000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15100000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
9444700000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13900000 USD
CY2019Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
29700000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
11700000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
109200000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
193100000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13000000.0 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
9755900000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
6144100000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13600000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
-700000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85800000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
478000000.0 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9700000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
6567600000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19800000 USD
CY2018Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
31900000 USD
CY2018Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
37600000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
113100000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
551400000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4100000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
7186500000 USD
us-gaap Net Income Loss
NetIncomeLoss
654200000 USD
us-gaap Net Income Loss
NetIncomeLoss
1029400000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
103100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
70000000.0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
213700000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
189200000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-110700000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
54900000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
125300000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
15500000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
256800000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
64900000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
168200000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
182100000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-42500000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-59400000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
401100000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-84200000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
110300000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
67000000.0 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
431100000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-16000000.0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1085300000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1013400000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2189100000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1181200000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
745900000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
462200000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
168900000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
191400000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1612100000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-910400000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
155100000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
34100000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
40500000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
31900000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
10000000.0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
104600000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2200000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-422200000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
105200000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1480200000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
825200000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1058000000.0 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
930400000 USD
CY2018Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
91400000 USD
us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
332400000 USD
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
258300000 USD
CY2019Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
165500000 USD
CY2017Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
85300000 USD
us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
219700000 USD
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
214000000.0 USD
CY2018Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
91000000.0 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
193100000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
551400000 USD
us-gaap Net Income Loss
NetIncomeLoss
654200000 USD
us-gaap Net Income Loss
NetIncomeLoss
1029400000 USD
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109200000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109100000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107700000 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5400000 shares
CY2018Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6700000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5900000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000000.0 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114600000 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115000000.0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114700000 shares
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.77
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.56
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.68
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.82
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.97
CY2019Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4073700000 USD
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
23000000.0 USD
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1900000 USD
CY2019Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4094800000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3026600000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000000.0 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
18400000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3009200000 USD
CY2019Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1624200000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1342200000 USD
CY2019Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2470600000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1667000000.0 USD
CY2019Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4094800000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3009200000 USD
CY2019Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
312800000 USD
CY2019Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
200000 USD
CY2019Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
641100000 USD
CY2019Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1700000 USD
CY2019Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
953900000 USD
CY2019Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
1900000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1482600000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
6100000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
900700000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
12300000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
2383300000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
18400000 USD
CY2019Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-116900000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-74100000 USD
CY2018Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
16500000 USD
CY2018Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
723900000 USD
CY2018Q4 us-gaap Capital Leases Net Investment In Direct Financing Leases Accumulated Amortization
CapitalLeasesNetInvestmentInDirectFinancingLeasesAccumulatedAmortization
61700000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
25900000 USD
CY2019Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
45500000 USD
CY2019Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
229700000 USD
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
226800000 USD
CY2019Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
663100000 USD
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
571100000 USD
CY2019Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
34100000 USD
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
24400000 USD
CY2019Q2 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
390300000 USD
CY2018Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
328900000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
1317200000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
1151200000 USD
CY2019Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
667300000 USD
CY2019Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
711300000 USD
CY2019Q2 regn Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
2900000 USD
CY2019Q2 regn Finance Lease Liability Payments Due Year Six
FinanceLeaseLiabilityPaymentsDueYearSix
0 USD
CY2019Q2 regn Lessee Operating Lease Liability Payments Due After Year Six
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix
4200000 USD
CY2019Q2 regn Finance Lease Liability Payments Due After Year Six
FinanceLeaseLiabilityPaymentsDueAfterYearSix
0 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2600000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0 USD
CY2019Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3700000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
7200000 USD
CY2019Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
7300000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
14500000 USD
CY2019Q2 regn Finance Lease Cost
FinanceLeaseCost
11000000.0 USD
regn Finance Lease Cost
FinanceLeaseCost
21700000 USD
regn Finance Lease Remaining Lease Term
FinanceLeaseRemainingLeaseTerm
P2Y8M1D
CY2019Q2 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.0314
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4000000.0 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
12000000.0 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8200000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
22100000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5800000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
21800000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3000000.0 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
725400000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
30700000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
781300000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3000000.0 USD
CY2019Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
63300000 USD
CY2019Q2 regn Lessee Operating Lease Liability Debt Financing Costs
LesseeOperatingLeaseLiabilityDebtFinancingCosts
0 USD
CY2019Q2 regn Lessee Finance Lease Liability Debt Financing Costs
LesseeFinanceLeaseLiabilityDebtFinancingCosts
6700000 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
27700000 USD
CY2019Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
711300000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
10400000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
26400000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3800000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
28400000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3400000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
27900000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2200000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
7000000.0 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1500000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
0 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4100000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
25400000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
89700000 USD
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.141
CY2018Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.160
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.151
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.171
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1045500000 USD
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
917900000 USD
CY2019Q2 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2018Q2 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1058000000.0 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
930400000 USD
CY2019Q2 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
74700000 USD
CY2018Q4 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
54500000 USD
CY2018Q2 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
38400000 USD
CY2017Q4 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
41800000 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
Recently Issued Accounting Standards <div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-13, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments </span><span style="font-family:inherit;font-size:10pt;">("ASU 2016-13"). ASU 2016-13 requires an entity to measure and recognize expected credit losses for certain financial instruments, including trade receivables, as an allowance that reflects the entity's current estimate of credit losses expected to be incurred. For available-for-sale debt securities with unrealized losses, the standard requires allowances to be recorded instead of reducing the amortized cost of the investment. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019, with early adoption permitted. We do not expect the adoption of this standard to have a significant impact on our financial statements or internal controls; however, the ultimate impact will depend on the composition of the Company's portfolio of financial instruments as of the adoption date.</span></div>

Files In Submission

Name View Source Status
0001532176-19-000026-index-headers.html Edgar Link pending
0001532176-19-000026-index.html Edgar Link pending
0001532176-19-000026.txt Edgar Link pending
0001532176-19-000026-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
regn-063019x10q.htm Edgar Link pending
regn-063019x10q_htm.xml Edgar Link completed
regn-20190630.xsd Edgar Link pending
regn-20190630_cal.xml Edgar Link unprocessable
regn-20190630_def.xml Edgar Link unprocessable
regn-20190630_lab.xml Edgar Link unprocessable
regn-20190630_pre.xml Edgar Link unprocessable
regn-ex104.htm Edgar Link pending
regn-ex1041.htm Edgar Link pending
regn-ex1042.htm Edgar Link pending
regn-ex105.htm Edgar Link pending
regn-ex106.htm Edgar Link pending
regn-ex311x06302019x10q.htm Edgar Link pending
regn-ex312x06302019x10q.htm Edgar Link pending
regn-ex32x06302019x10q.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending